<DOC>
	<DOCNO>NCT00171925</DOCNO>
	<brief_summary>Multiple myeloma disease B-lymphocytes produce malignant plasma cell . Malignant plasma cell induce osteolytic lesion , characteristic progression multiple myeloma . It aim study investigate whether zoledronic acid influence progression multiple myeloma .</brief_summary>
	<brief_title>Therapy With Zoledronic Acid Patients With Multiple Myeloma Stage I</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Inclusion Criteria Evidence myeloma accord criterion British Columbia Cancer Agency ( diagnosis , 2 3 criterion must meet ) : Evidence paraprotein serum urine Bone marrow infiltration plasma cell represent 10 % nucleated cell Radiologically , least one osteolytic lesion Asymptomatic patient Stage I ( Durie Salmon ) multiple myeloma Exclusion criterion : Patients one osteolytic lesion conventional skeletal radiography Previous treatment bisphosphonates bilirubin &gt; 2.5 mg/dl Abnormal renal function evidence : A calculated creatinine clearance &lt; 30 ml/minute . Creatinine clearance ( CrCl ) calculate use CockcroftGault formula : CrCl= [ 140age ( year ) ] x weight ( kg ) / [ 72xserumcreatinine ( mg/dL ) ] X { 0.85 female patient } Patients malignant disease severe concomitant disease Potentially fertile patient use reliable appropriate method contraception Pregnancy breastfeed Participation another clinical study investigational drug within 12 week study entry Current active dental problem include infection teeth jawbone ( maxilla mandibular ) ; dental fixture trauma , current prior diagnosis osteonecrosis jaw ( ONJ ) , expose bone mouth , slow healing dental procedure . Recent ( within 6 week ) plan dental jaw surgery ( e.g.. extraction , implant ) Other protocoldefined inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Stage I</keyword>
	<keyword>Zoledronic acid</keyword>
	<keyword>Progression</keyword>
</DOC>